Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes

1 augusti 2026 uppdaterad av: Seda Yıldız, Halic University

Investigation Of Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes: A Cross-Sectional Study

Paralympic athletes actively participate in many sports despite their physical limitations and continue to develop both individually and athletically. Assessing the physical and functional capacities of these athletes is important in terms of performance and health. This study aimed to examine the relationships between respiratory function, respiratory muscle strength, lung age, balance, and quality of life in Paralympic athletes. Additionally, it was evaluated whether there were significant differences in these parameters according to disability type and gender.

The study included 24 Paralympic athletes from the disciplines of athletics, swimming, archery, and wheelchair basketball. Participants had various orthopeadic and neurological disability types, including cerebral palsy, lower extremity amputation, spinal cord injuries (C5-T6 and T7 and below), hypotonia, poliomyelitis, spina bifida, brachial plexus injury, and short stature. Respiratory function was assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and forced expiratory flow (FEF25-75%); respiratory muscle strength was assessed using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Lung age was calculated based on FEV₁ values, balance was measured using the Modified Functional Reach Test, and quality of life was determined using the Short Form (SF-36) questionnaire. Significant correlations were found between parameters. Based on the study results, supporting respiratory muscle strength in Paralympic athletes may be an important goal in rehabilitation and training programs to support respiratory function, lung age, and quality of life parameters.

Studieöversikt

Status

Avslutad

Studietyp

Observationell

Inskrivning (Faktisk)

24

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Nej

Testmetod

Sannolikhetsprov

Studera befolkning

Paralympic athletes who has been playing their sports minimum 1 year participated in the study.

Beskrivning

Inclusion Criteria:

  • Being between 18-50 years of age
  • Being registered with any of the sports federations in Turkey and being a licensed paralympic athlete for at least 1 year (
  • Having a lower extremity or upper extremity amputation or having permanent injuries as determined by the International Paralympic Committee

Exclusion Criteria:

  • Lack of consent to participate in the study.
  • Having undergone surgery within the last 6 months.
  • Having had a respiratory tract infection within the three weeks prior to the evaluations
  • FEV1/FVC < 0.7

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Forced expiratory volume in the first second (FEV1) (L)
Tidsram: 4 months

Pulmonary function (Forced expiratory volume in the first second FEV1)) was evaluated with a portable spirometer, COSMED Pony FX® (COSMED S.r.l., Italy) and measurements were performed according to European Respiratory Society standards.

Considering that dizziness may occur during forced expiration, measurements were made while individuals were in a sitting position. While participants were sitting in a comfortable position in a chair with a backrest, nose clip was attached and they were asked to bite the mouth teeth and close their lips in a way that did not allow air to escape. The tests were performed at least 3 times by the participants and care was taken to ensure that the expiration time was at least 6 seconds and the plateau time was 1 second. Due to the device software that records all three data, it saved the average of the two best data and processed it as a value.

4 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Forced vital capacity (FVC) (L)
Tidsram: 4 months
Pulmonary function ((Forced vital capacity (FVC )) was evaluated with a portable spirometer.
4 months
FEV1 / FVC (%)
Tidsram: 4 months
Pulmonary function (FEV1 / FVC) was evaluated with a spirometer.
4 months
Peak flow rate (PEF) (L/s)
Tidsram: 4 months
Pulmonary function (Peak flow rate (PEF)) was evaluated with a spirometer.
4 months
Flow rate 25-75% of forced expiratory volume (FEF 25-75%) (L/s)
Tidsram: 4 months
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) was evaluated with a spirometer.
4 months
Maximal expiratory pressure (MEP) (L)
Tidsram: 4 months
The MEP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
4 months
Maximal inspiratory pressure (MIP) (L)
Tidsram: 4 months
The MIP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
4 months
Balance
Tidsram: 4 months
Balance was measured using the Modified Functional Reach Test
4 months
Quality of Life
Tidsram: 4 months
Quality of life was determined using the Short Form-36 (SF-36) Health Survey that contains 36 questions and produces scores for eight health related quality of life domains. Each domain is transformed to a 0-100 scale. Higher scores represents better health status while lower stores represents poor health status.
4 months
Lung Age
Tidsram: 4 months
Lung age was calculated based on FEV₁ values. For male: Lung age (years)=(2.87×height in cm×0.394)-(31.25×FEV1 in L)-39.375 For females: Lung age (years)=(3.56×height in cm×0.394)-(40×FEV1 in L)-77.280
4 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 december 2024

Primärt slutförande (Faktisk)

31 maj 2025

Avslutad studie (Faktisk)

30 juni 2025

Studieregistreringsdatum

Först inskickad

26 juni 2026

Först inskickad som uppfyllde QC-kriterierna

1 augusti 2026

Första postat (Faktisk)

6 augusti 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 augusti 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

1 augusti 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • Paralympic_Athlete

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

Quality of life and balance results can be shared.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera